Article Versions Notes

Kumarihamy M, Tripathi S, Balachandran P, Avula B, Zhao J, Wang M, Bennett MM, Zhang J, Carr MA, Lovell KM, et al. Synthesis and Inhibitory Activity of Machaeridiol-Based Novel Anti-MRSA and Anti-VRE Compounds and Their Profiling for Cancer-Related Signaling Pathways. Molecules. 2022; 27(19):6604. https://doi.org/10.3390/molecules27196604

Kumarihamy, Mallika, Siddharth Tripathi, Premalatha Balachandran, Bharathi Avula, Jianping Zhao, Mei Wang, Maria M. Bennett, Jin Zhang, Mary A. Carr, K. Michael Lovell, and et al. 2022. "Synthesis and Inhibitory Activity of Machaeridiol-Based Novel Anti-MRSA and Anti-VRE Compounds and Their Profiling for Cancer-Related Signaling Pathways" Molecules 27, no. 19: 6604. https://doi.org/10.3390/molecules27196604

Kumarihamy, M., Tripathi, S., Balachandran, P., Avula, B., Zhao, J., Wang, M., Bennett, M. M., Zhang, J., Carr, M. A., Lovell, K. M., Wellington, O. I., Marquart, M. E., Nanayakkara, N. P. D., & Muhammad, I. (2022). Synthesis and Inhibitory Activity of Machaeridiol-Based Novel Anti-MRSA and Anti-VRE Compounds and Their Profiling for Cancer-Related Signaling Pathways. Molecules, 27(19), 6604. https://doi.org/10.3390/molecules27196604